MX2021008479A - Enzimas dependientes de aril sulfato modificadas por ingenieria genetica. - Google Patents

Enzimas dependientes de aril sulfato modificadas por ingenieria genetica.

Info

Publication number
MX2021008479A
MX2021008479A MX2021008479A MX2021008479A MX2021008479A MX 2021008479 A MX2021008479 A MX 2021008479A MX 2021008479 A MX2021008479 A MX 2021008479A MX 2021008479 A MX2021008479 A MX 2021008479A MX 2021008479 A MX2021008479 A MX 2021008479A
Authority
MX
Mexico
Prior art keywords
engineered
sulfotransferase
activity
glucosaminyl
heparosan
Prior art date
Application number
MX2021008479A
Other languages
English (en)
Spanish (es)
Inventor
Tarsis Gesteira Ferreira
Original Assignee
Optimvia Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimvia Llc filed Critical Optimvia Llc
Publication of MX2021008479A publication Critical patent/MX2021008479A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/13Transferases (2.) transferring sulfur containing groups (2.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/64Preparation of S-glycosides, e.g. lincomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y208/00Transferases transferring sulfur-containing groups (2.8)
    • C12Y208/02Sulfotransferases (2.8.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y208/00Transferases transferring sulfur-containing groups (2.8)
    • C12Y208/02Sulfotransferases (2.8.2)
    • C12Y208/02008[Heparan sulfate]-glucosamine N-sulfotransferase (2.8.2.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y208/00Transferases transferring sulfur-containing groups (2.8)
    • C12Y208/02Sulfotransferases (2.8.2)
    • C12Y208/02023[Heparan sulfate]-glucosamine 3-sulfotransferase 1 (2.8.2.23)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
MX2021008479A 2019-01-15 2020-01-15 Enzimas dependientes de aril sulfato modificadas por ingenieria genetica. MX2021008479A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962792440P 2019-01-15 2019-01-15
US201962797466P 2019-01-28 2019-01-28
US201962808074P 2019-02-20 2019-02-20
US201962853261P 2019-05-28 2019-05-28
PCT/US2020/013677 WO2020150350A1 (en) 2019-01-15 2020-01-15 Engineered aryl sulfate-dependent enzymes

Publications (1)

Publication Number Publication Date
MX2021008479A true MX2021008479A (es) 2021-10-13

Family

ID=69529057

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008479A MX2021008479A (es) 2019-01-15 2020-01-15 Enzimas dependientes de aril sulfato modificadas por ingenieria genetica.

Country Status (10)

Country Link
US (9) US11692180B2 (https=)
EP (1) EP3911737A1 (https=)
JP (1) JP2022523638A (https=)
KR (1) KR20210126019A (https=)
CN (1) CN113646427A (https=)
AU (1) AU2020209822A1 (https=)
BR (1) BR112021013890A2 (https=)
CA (1) CA3126805A1 (https=)
MX (1) MX2021008479A (https=)
WO (1) WO2020150350A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113646427A (zh) * 2019-01-15 2021-11-12 奥普蒂姆维亚有限公司 工程化芳基硫酸酯依赖性酶
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CA3144968A1 (en) * 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
CN114763570B (zh) * 2021-09-10 2024-02-27 江南大学 制备不同分子量肝素的磺酸化修饰体系构建及其应用
CN117467632B (zh) * 2022-07-27 2024-09-24 江南大学 一种肝素n-磺基转移酶突变体构建方法
CN115975040B (zh) * 2022-07-28 2026-02-27 重庆东渝中能实业有限公司 埃氏拟杆菌肝素酶i融合蛋白及其编码基因和制备方法
CN119662591B (zh) * 2025-01-20 2025-11-04 江南大学 一种肝素2-o-磺基转移酶高活性突变体的构建方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5541095A (en) 1992-06-16 1996-07-30 University Of Massachusetts Medical Center Glycosaminoglycan specific sulfotransferases
JP3818676B2 (ja) 1994-07-22 2006-09-06 生化学工業株式会社 ヘパラン硫酸6−o−硫酸基転移酵素
US5919673A (en) 1995-03-22 1999-07-06 The Scripps Research Institute One-pot enzymatic sulfation process using 3'-phosphoadenosine-5'-phosphosulfate and recycled phosphorylated adenosine intermediates
JP3672359B2 (ja) 1995-07-24 2005-07-20 生化学工業株式会社 ヘパラン硫酸 2−o−硫酸基転移酵素
JP3964982B2 (ja) 1997-06-19 2007-08-22 生化学工業株式会社 ヘパラン硫酸6−o硫酸基転移酵素のポリペプチド及びそれをコードするdna
AU1199799A (en) * 1997-10-24 1999-05-17 Massachusetts Institute Of Technology Heparan sulfate d-glucosaminyl 3-(o)-sulfotransferases, an uses therefor
US6861254B1 (en) 1997-10-24 2005-03-01 Massachusetts Institute Of Technology Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor
US7307159B2 (en) 2001-05-08 2007-12-11 The Board Of Regents Of The University Of Oklahoma Heparin/heparosan synthase from P. multocida and methods of making and using same
US20060188966A1 (en) 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
US8088604B2 (en) 1998-04-02 2012-01-03 The Board Of Regents Of The University Of Oklahoma Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
DE69934890D1 (de) 1998-06-16 2007-03-08 Univ Oklahoma Glykosulfopeptide und verfahren zu deren herstellung und deren verwendung
US6255088B1 (en) 1999-05-11 2001-07-03 The Scripps Research Institute Enzymatic sulfation of biomolecules
DE10002005A1 (de) 2000-01-19 2001-08-09 Bosch Gmbh Robert Zerstäubungsdüse
ITMI20010397A1 (it) 2001-02-27 2002-08-27 Giorgio Zoppetti Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
US8067196B2 (en) 2001-03-28 2011-11-29 Massachusetts Institute Of Technology 6-O sulfated polysaccharides and methods of preparation thereof
US8580290B2 (en) 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
WO2004005475A2 (en) 2002-07-05 2004-01-15 University Of North Carolina At Chapel Hill Purified and isolated heparan sulfate 3-o-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same
US20040147469A1 (en) 2002-11-01 2004-07-29 Case Western Reserve University Methods of inhibiting glial scar formation
AU2003293122A1 (en) 2002-11-27 2004-06-23 Massachusetts Institute Of Technology Methods for synthesizing polysaccharides
US7655445B2 (en) * 2003-11-12 2010-02-02 Massachusetts Institute Of Technology Methods for synthesis of sulfated saccharides
WO2006023487A2 (en) 2004-08-16 2006-03-02 Massachusetts Institute Of Technology Rapid two-step synthesis of anti-coagulants
US20060154894A1 (en) 2004-09-15 2006-07-13 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
CA2594013A1 (en) 2005-01-12 2006-07-20 Massachusetts Institute Of Technology Methods and compositions related to modulating the extracellular stem cell environment
WO2006124801A2 (en) * 2005-05-12 2006-11-23 The University Of North Carolina At Chapel Hill Enzymatic synthesis of sulfated polysaccharides
BRPI0612687B1 (pt) 2005-07-05 2019-05-14 Huawei Technologies Co., Ltd. Método de autenticação em subsistema multimídia ip
WO2009014715A2 (en) 2007-07-23 2009-01-29 The University Of North Carolina At Chapel Hill Enzymatic synthesis of sulfated polysaccharides without iduronic acid residues
WO2010003023A2 (en) 2008-07-01 2010-01-07 Zacharon Pharmaceuticals, Inc. Heparan sulfate inhibitors
CN101724086B (zh) 2009-11-25 2012-09-26 深圳海王药业有限公司 低聚凤梨参糖胺聚糖及其制备方法
US11203772B2 (en) 2010-12-23 2021-12-21 The University Of North Carolina At Chapel Hill Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins
TW201309305A (zh) 2011-02-22 2013-03-01 Rensselaer Polytech Inst 用於製造生物工程肝素之單一步驟肝素前體之n-去乙醯化作用及解聚合作用
US8815529B2 (en) 2011-05-23 2014-08-26 Research & Diagnostics Systems, Inc. Sulfotransferase assay
CA2869128C (en) 2012-03-30 2022-07-26 The Board Of Regents Of The University Of Oklahoma High molecular weight heparosan polymers and methods of production and use thereof
US20140349962A1 (en) 2013-05-24 2014-11-27 Massachusetts Institute Of Technology Rapid two-step synthesis of anti-coagulants
ES2924830T3 (es) 2013-06-17 2022-10-11 Univ North Carolina Chapel Hill Moléculas de heparina reversibles
HUE047658T2 (hu) 2014-08-22 2020-05-28 Cysbio Aps Biológiai eljárás szulfatált fenolvegyület elõállítására
JP6879216B2 (ja) 2015-12-28 2021-06-02 味の素株式会社 抗凝固活性を有するヘパラン硫酸の製造法
EP3420095A1 (en) 2016-02-24 2019-01-02 Danmarks Tekniske Universitet Improved biological processes for the production of aryl sulfates
TWI769176B (zh) 2016-09-07 2022-07-01 瑞瑟勒綜合技術協會 生合成肝素
CN110191958B (zh) 2017-01-19 2024-06-25 味之素株式会社 生产具有经异构化的己糖醛酸残基的肝素前体化合物的方法
CN110446511B (zh) 2017-03-10 2024-04-02 北卡罗来纳大学查珀尔希尔分校 短效的基于肝素的抗凝血剂化合物和方法
CN117417912A (zh) 2017-09-05 2024-01-19 味之素株式会社 2-o-硫酸化酶突变体和3-o-硫酸化酶突变体及其使用方法
CN113646427A (zh) * 2019-01-15 2021-11-12 奥普蒂姆维亚有限公司 工程化芳基硫酸酯依赖性酶
US11708593B2 (en) * 2019-01-15 2023-07-25 Optimvia, Llc Engineered aryl sulfate-dependent enzymes

Also Published As

Publication number Publication date
US20220340888A9 (en) 2022-10-27
US11572549B2 (en) 2023-02-07
US11692180B2 (en) 2023-07-04
AU2020209822A1 (en) 2021-09-09
US11773382B2 (en) 2023-10-03
US20220042062A1 (en) 2022-02-10
US20210363503A1 (en) 2021-11-25
CA3126805A1 (en) 2020-07-23
US20240002819A1 (en) 2024-01-04
BR112021013890A2 (pt) 2021-09-21
US20230029317A1 (en) 2023-01-26
CN113646427A (zh) 2021-11-12
US11473068B2 (en) 2022-10-18
US20240093166A1 (en) 2024-03-21
US20230051957A1 (en) 2023-02-16
US11572550B2 (en) 2023-02-07
US20210363505A1 (en) 2021-11-25
JP2022523638A (ja) 2022-04-26
EP3911737A1 (en) 2021-11-24
US11767518B2 (en) 2023-09-26
US20210363504A1 (en) 2021-11-25
KR20210126019A (ko) 2021-10-19
WO2020150350A1 (en) 2020-07-23
US20230092183A1 (en) 2023-03-23
US11708567B2 (en) 2023-07-25

Similar Documents

Publication Publication Date Title
MX2021008479A (es) Enzimas dependientes de aril sulfato modificadas por ingenieria genetica.
ZA201802331B (en) Stable inoculant compositions and methods for producing same
MX2023008013A (es) Sistemas y dispositivos para control de movimiento.
Chang et al. Isolation and characterization of a sea cucumber fucoidan‐utilizing marine bacterium
BR112022009600A2 (pt) Paenibacillus peoriae fixador de nitrogênio isolado, cultura biologicamente pura de um paenibacillus peoriae fixador de nitrogênio, uso de um ou mais paenibacillus peoriae fixadores de nitrogênio e do consórcio microbiano sintético, método, composição inoculante e de sementes de ocorrência não natural, e, consórcio microbiano sintético
MX2021011119A (es) Nueva cepa de paenibacillus, compuestos antifungicos y metodos para su uso.
MX2022000343A (es) Metodos para sintetizar polisacaridos anticoagulantes.
MX392155B (es) Composiciones y metodos para la biosintesis de vainillina o de beta-d-glucosido de vainillina.
WO2009038842A3 (en) Methods and compositions to inhibit edema factor and adenylyl cyclase
CY1107399T1 (el) Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια
MX2022012561A (es) Composiciones y metodos para silenciar la expresion de la subunidad alfa tipo ix dependiente del voltaje del canal de sodio (scn9a).
MX2024006674A (es) Almidones cerosos inhibidos y sus metodos de uso.
MX2019008872A (es) Prevencion y tratamiento de da?o o enfermedad osea y cartilago.
RU2009136544A (ru) Способ получения l-цистеина с использованием бактерии семейства enterobacteriaceae
EA201790856A1 (ru) Новый сульфат декстрана
EP4473976A3 (en) Stable ascorbic acid compositions and methods of using the same
WO2010019775A3 (en) Methods of treating ras driven cancer in a subject
PH12020550476A1 (en) Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration
BR112012008536A2 (pt) caroços de algodão felpudo que compreendem um revestimento de poliuretano aquoso
SG148171A1 (en) Methods of proliferating stem cells
MX2020011986A (es) Composiciones que comprenden glucosa y hemicelulosa y su uso.
HK1252426A1 (zh) 胰岛移植的改良方法
SG137815A1 (en) Stable starches for contributing dietary fiber to food compositions
EA201000129A1 (ru) Способ диафрагмализа и применение полученных этим способом продуктов
GEAP202316346A (en) Compositions comprising exopolysaccharides and uses thereof